These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 19536819)

  • 41. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
    Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
    Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implications of genetic testing of hereditary nonpolyposis colorectal cancer.
    Vasen HF; Wijnen J
    Cytogenet Cell Genet; 1999; 86(2):136-9. PubMed ID: 10545704
    [No Abstract]   [Full Text] [Related]  

  • 43. Decoding hereditary colorectal cancer.
    Boland CR
    N Engl J Med; 2006 Jun; 354(26):2815-7. PubMed ID: 16807419
    [No Abstract]   [Full Text] [Related]  

  • 44. Uterine carcinosarcoma associated with hereditary nonpolyposis colorectal cancer.
    South SA; Hutton M; Farrell C; Mhawech-Fauceglia P; Rodabaugh KJ
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):543-5. PubMed ID: 17666659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
    Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene symbol: MLH1. Disease: Hereditary nonpolyposis colorectal cancer.
    Otway R; Tetlow N; Hornby J; Doe WF; Kohonen-Corish MR
    Hum Genet; 2005 May; 116(6):535. PubMed ID: 15991306
    [No Abstract]   [Full Text] [Related]  

  • 48. Cell-free assay breakthrough for MLH1 variants.
    Hofstra RM; Sijmons RH
    Hum Mutat; 2010 Mar; 31(3):v. PubMed ID: 20162719
    [No Abstract]   [Full Text] [Related]  

  • 49. A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.
    van Lier MG; Wagner A; van Leerdam ME; Biermann K; Kuipers EJ; Steyerberg EW; Dubbink HJ; Dinjens WN
    J Cell Mol Med; 2010 Jan; 14(1-2):181-97. PubMed ID: 19929944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identifying Lynch syndrome: we are all responsible.
    Sanchez JA; Vogel JD; Kalady MF; Bronner MP; Skacel M; Church JM
    Dis Colon Rectum; 2008 Dec; 51(12):1750-6. PubMed ID: 18682882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of cancer in cases of suspected lynch syndrome without germline mutation.
    Rodríguez-Soler M; Pérez-Carbonell L; Guarinos C; Zapater P; Castillejo A; Barberá VM; Juárez M; Bessa X; Xicola RM; Clofent J; Bujanda L; Balaguer F; Reñé JM; de-Castro L; Marín-Gabriel JC; Lanas A; Cubiella J; Nicolás-Pérez D; Brea-Fernández A; Castellví-Bel S; Alenda C; Ruiz-Ponte C; Carracedo A; Castells A; Andreu M; Llor X; Soto JL; Payá A; Jover R
    Gastroenterology; 2013 May; 144(5):926-932.e1; quiz e13-4. PubMed ID: 23354017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What's new in hereditary colorectal cancer?
    Jass JR
    Arch Pathol Lab Med; 2005 Nov; 129(11):1380-4. PubMed ID: 16253015
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Point: justification for Lynch syndrome screening among all patients with newly diagnosed colorectal cancer.
    Hampel H
    J Natl Compr Canc Netw; 2010 May; 8(5):597-601. PubMed ID: 20495086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside.
    Boland CR; Koi M; Chang DK; Carethers JM
    Fam Cancer; 2008; 7(1):41-52. PubMed ID: 17636426
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetics of hereditary nonpolyposis colorectal cancer.
    Akrami SM
    Arch Iran Med; 2006 Oct; 9(4):381-9. PubMed ID: 17061614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new interphase fluorescence in situ hybridization approach for genomic rearrangements involving MLH1 and MSH6 in hereditary nonpolyposis colorectal cancer-suspected mutation-negative patients.
    Koehler U; Grabowski M; Bacher U; Holinski-Feder E
    Cancer Genet Cytogenet; 2007 May; 175(1):81-4. PubMed ID: 17498565
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC).
    Hegde MR; Roa BB
    Curr Protoc Hum Genet; 2009 Apr; Chapter 10():Unit 10.12. PubMed ID: 19360696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis.
    Alemayehu A; Tomkova K; Zavodna K; Ventusova K; Krivulcik T; Bujalkova M; Bartosova Z; Fridrichova I
    Neoplasma; 2007; 54(5):391-401. PubMed ID: 17688369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple synchronous primary ovarian malignancies in a patient with a MLH-1 mutation: Impact on potential fertility preservation.
    Phippen NT; Lowery WJ; Banks NB; Leath CA
    Gynecol Oncol; 2011 Jun; 121(3):637-8. PubMed ID: 21353691
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.